Shanghai Runda Med Tech Co (603108) — Cash Flow Reinvestment Rate

Latest as of June 2023: 0.50x

Shanghai Runda Med Tech Co (603108) has a Cash Flow Reinvestment Rate of 0.50x as of June 2023, reinvesting CN¥71.74 Million (capex CN¥68.54 Million plus investments CN¥-3.20 Million) from operating cash flow of CN¥144.38 Million. See Shanghai Runda Med Tech Co free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.50x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥71.74 Million
Capex + Investments

Operating Cash Flow

CN¥144.38 Million
CNY

Capital Expenditures

CN¥68.54 Million
CNY

Shanghai Runda Med Tech Co Cash Flow Reinvestment Rate (2014–2024)

Historical reinvestment intensity for Shanghai Runda Med Tech Co across 7 annual periods. For the full cash flow conversion analysis, see 603108 operating cash flow.

Annual Cash Flow Reinvestment Rate for Shanghai Runda Med Tech Co (2014–2024)

Year-by-year capital reinvestment analysis for Shanghai Runda Med Tech Co. See Shanghai Runda Med Tech Co (603108) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 1.07x CN¥689.83 Million CN¥646.95 Million CN¥229.16 Million ▲ +42.2%
2023 0.75x CN¥547.22 Million CN¥729.72 Million CN¥319.88 Million ▼ -8.0%
2021 0.82x CN¥302.47 Million CN¥371.11 Million CN¥301.09 Million ▼ -58.7%
2020 1.97x CN¥638.19 Million CN¥323.44 Million CN¥331.94 Million ▲ +60.2%
2019 1.23x CN¥303.75 Million CN¥246.68 Million CN¥288.73 Million ▲ +92.4%
2018 0.64x CN¥344.92 Million CN¥538.90 Million CN¥264.43 Million ▼ -81.6%
2014 3.47x CN¥125.35 Million CN¥36.11 Million CN¥125.35 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow